A highly efficient transgene knock-in technology in clinically relevant cell types

Recommended Posts

Shoreline Biosciences to Present at 2024 Stifel Healthcare Conference
A Steadying Force in C-Suite: The Changing Role of Biopharma CFOs
BioWorld Insider Podcast: One-on-one with Medical Innovators